Spontaneous appearance of Tay-Sachs disease in an animal model

Molecular Genetics and Metabolism

Volumn 95, Issue 1-2, 2008, Pages 59-65

  Zeng, B J ^a   Torres, P A ^a   Viner, T C ^b   Wang, Z H ^c   Raghavan, S S ^a   Alroy, J ^d   Pastores, G M ^a   Kolodny, E H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SMITHSONIAN CONSERVATION BIOLOGY INSTITUTE   (United States)

^c NEW YORK DOWNTOWN HOSPITAL   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hexosaminidase A gene; Animal model; Lysosomal storage disorder; Missense mutation; Tay Sachs disease

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; GANGLIOSIDE GM2; NUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TAY SACHS DISEASE;

ANIMALS; AVIAN PROTEINS; BIRDS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HEXOSAMINIDASE A; HUMANS; LIPID METABOLISM; MALE; MUTATION; TAY-SACHS DISEASE;

ANIMALIA; PHOENICOPTERUS RUBER;

EID: 51649118272     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.06.010     Document Type: Article

References (42)

1. Montalvo A.L., Filocamo M., Vlahovicek K., Dardis A., Lualdi S., Corsolini F., Bembi B., and Pittis M.G. Molecular analysis of the HEXA gene in Italian patients with infantile and late onset Tay-Sachs disease: detection of fourteen novel alleles. Hum. Mutat. 26 (2005) 282
2. m2 gangliosidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease vol. 4 (2001), Mcgraw-Hill, New York 2839-2869
3. Triggs-Raine B.L., Akerman B.R., Clarke J.T., and Gravel R.A. Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease. Am. J. Hum. Genet. 49 (1991) 1041-1054
4. Proia R.L., and Soravia E. Organization of the gene encoding the human B-hexosaminidase α-chain. J. Biol. Chem. 262 (1987) 5677-5681
5. Norflus F., Tifft C.J., McDonald M.P., Goldstein G., Crawley J.N., Hoffmann A., Sandhoff K., Suzuki K., and Proia R.L. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestation in Sandhoff disease mice. J. Clin. Invest. 101 (1998) 1881-1888
6. Cachon-Gonzalez M.B., Wang S.Z., Lynch A., Ziegler R., Cheng S.H., and Cox T.M. Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc. Natl. Acad. Sci. USA 103 (2006) 10373-10378
7. Arfi A., Zisling R., Richard E., Batista L., Poenaru L., Futerman A.H., and Caillaud C. Reversion of the biochemical defects in murine embryonic Sandhoff neurons using a bicistronic lentiviral vector encoding hexosaminidase alpha and beta. J. Neurochem. 96 (2006) 1572-1579
8. Bembi B., Marchetti F., Guerci V.I., Ciana G., Addobbati R., Grasso D., Barone R., Cariati R., Fernandez-Guillen L., Butters T., and Pittis M.G. Substrate reduction therapy in the infantile form of Tay-Sachs disease. Neurology 66 (2006) 278-280
9. Martino S., Cavalieri C., Emiliani C., Dolcetta D., Gusella De Angelis M.G., Chigorno V., Severini G.M., Sandhoff K., Bordignon C., and Orlacchio A. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model. Neurochem. Res. 27 (2002) 793-800
10. Tsuji D., Kuroki A., Ishibashi Y., Itakura T., and Itoh K. Metabolic correction in microglia derived from Sandhoff disease model mice. J. Neurochem. 94 (2005) 1631-1638
11. Bourgoin C., Emiliani C., Kremer E.J., Gelot A., Tancini B., Gravel R.A., Drugan C., Orlacchio A., Poenaru L., and Caillaud C. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol. Gene Ther. 10 (2003) 1841-1849
12. Yamaguchi A., Katsuyama K., Suzuki K., Kosaka K., Aoki I., and Yamanaka S. Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease. J. Mol. Med. 81 (2003) 185-193
13. Jeyakumar M., Norflus F., Tifft C.J., Cortina-Borja M., Butters T.D., Proia R.L., Perry V.H., Dwek R.A., and Platt F.M. Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood 97 (2001) 327-329
14. Norflus F., Tifft C.J., McDonald M.P., Goldstein G., Crawley J.N., Hoffmann A., Sandhoff K., Suzuki K., and Proia R.L. Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice. J. Clin. Invest. 101 (1998) 1881-1888
15. Suzuki K., Sango K., Proia R.L., and Langaman C. Mice deficient in all forms of lysosomal beta-hexosaminidase show mucopolysaccharidosis-like pathology. J. Neuropathol. Exp. Neurol. 56 (1997) 693-703
16. m2 activator deficiency manifests cerebellar pathology and motor impairment. Proc. Natl. Acad. Sci. USA 94 (1997) 8138-8143
17. Miklyaeva E.I., Dong W., Bureau A., Fattahie R., Xu Y., Su M., Fick G.H., Huang J., Igdoura S., Hanai N., and Gravel R. Late onset Tay-Sachs disease in mice with targeted disruption of the HexA gene: behavioral changes and pathology of the central nervous system. Brain Res. 1001 (2004) 37-50
18. Taniike M., Yamanaka S., Proia R.L., Langaman C., Bone-Turrentine T., and Suzuki K. Neuropathology of mice with targeted disruption of HEXA gene a model of Tay-Sachs disease. Acta Neuropathol. 89 (1995) 296-304
19. Sango K., Yamanaka S., Hoffmann A., Okuda Y., Grinberg A., Westphal H., McDonald M.P., Crawley J.N., Sandhoff K., Suzuki K., and Proia R.L. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat. Genet. 11 (1995) 170-176
20. Martin D.R., Cox N.R., Morrison N.E., Kennamer D.M., Peck S.L., Dodson A.N., Gentry A.S., Griffin B., Rolsma M.D., and Baker H.J. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. Acta Neuropathol. 110 (2005) 443-450
21. Martin D.R., Krum B.K., Varadarajan G.S., Hathcock T.L., Smith B.F., and Baker H.J. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant. Exp. Neurol. 187 (2004) 30-37
22. Jeyakumar M., Smith D., Eliott-Smith E., Cortina-Borja M., Reinkensmeier G., Butters T.D., Lemm T., Sandhoff K., Perry V.H., Dwek R.A., and Platt F.M. An inducible mouse model of late onset Tay-Sachs disease. Neurobiol. Dis. 10 (2002) 201-210
23. Kolter T., and Sandhoff K. Glycosphingolipid degradation and animal models of GM2-gangliosidoses. J. Inherit. Metab. Dis. 21 (1998) 548-563
24. Phaneuf D., Wakamatsu N., Huang J.Q., Borowski A., Peterson A.C., Fortunato S.R., Ritter G., Igdoura S.A., Morales C.R., Benoit G., Akerman B.R., Leclerc D., Hanai N., Marth J.D., Trasler J.M., and Gravel R.A. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 5 (1996) 1-14
25. Kroll R.A., Pagel M.A., Roman-Goldstein S., Barkovich A.J., D'Agostino A.N., and Neuwelt E.A. White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities. Am. J. Neuroradiol. 16 (1995) 1219-1226
26. Taniike M., Yamanaka S., Proia R.L., Langaman C., Bone-Turrentine T., and Suzuki K. Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs disease. Acta Neuropathol. (Berl.) 89 (1995) 296-304
27. Muldoon L.L., Neuwelt E.A., Pagel M.A., and Weiss D.L. Characterization of the molecular defect in a feline model for type II GM2-gangliosidosis (Sandhoff disease). Am. J. Pathol. 144 (1994) 1109-1118
28. Neuwelt E.A., Johnson W.G., Blank N.K., Pagel M.A., Maslen-McClure C., McClure M.J., and Wu P.M. Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats. J. Clin. Invest. 76 (1985) 482-490
29. Fox J., Li Y.T., Dawson G., Alleman A., Johnsrude J., Schumacher J., and Homer B. Naturally occurring GM2 gangliosidosis in two Muntjak deer with pathological and biochemical features of human classical Tay-Sachs disease (type B GM2 gangliosidosis). Acta Neuropathol. 97 (1999) 57-62
30. Kolodny E.H., Kanfer J.N., Quirk J.M., and Brady R.O. Properties of a particle-bound enzyme from rat intestine that cleaves sialic acid from Tay-Sachs ganglioside. J. Biol. Chem. 246 (1971) 1426-1431
31. 2 gangliosidoses and observations on human Tay-Sachs and Sandhoff diseases. Hum. Mol. Genet. 6 (1997) 1879-1885
32. Zeng B.J., Wang Z.H., Ribeiro L.A., Leone P., De Gasperi R., Kim S.J., Raghavan S.S., Ong E., Pastores G.M., and Kolodny E.H. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. J. Inherit. Metab. Dis. 25 (2002) 557-570
33. M1-gangliosidosis. J. Inherit. Metab. Dis. 23 (2000) 593-606
34. Zeng B.J., Wang Z.H., Pastores G.M., Leone P., Torres P., and Kolodny E.H. Rapid detection of three large novel deletions of the aspartoacylase gene in non-Jewish patients with Canavan disease. Mol. Genet. Metab. 89 (2006) 156-163
35. De Gasperi R., Gama Sosa M.A., Battistini S., Yeretsian J., Raghavan S.S., Zelnik N., Leshinsky E., and Kolodny E.H. Late-onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr180 → His) in the Hex A alpha-chain gene. Neurology 47 (1996) 547-552
36. Drucker L., Hemli J.A., and Navon R. Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease. Hum. Mutat. 10 (1997) 451-457
37. Petroulakis E., Cao Z., Clarke J.T., Mahuran D.J., Lee G., and Triggs-Raine B. W474C amino acid substitution affects early processing of the alpha-subunit of beta-hexosaminidase A and is associated with subacute G(M2) gangliosidosis. Hum. Mutat. 11 (1998) 432-442
38. Akalin N., Shi H.P., Vavougios G., Hechtman P., Lo W., Scriver C.R., Mahuran D., and Kaplan F. Novel Tay-Sachs disease mutations from China. Hum. Mutat. 1 (1992) 40-46
39. Fernandes M.J., Hechtman P., Boulay B., and Kaplan F. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts. Eur. J. Hum. Genet. 5 (1997) 129-136
40. Trop I., Kaplan F., Brown C., Mahuran D., and Hechtman P. A glycine250 → aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family. Hum. Mutat. 1 (1992) 35-39
41. Hepbildikler S.T., Sandhoff R., Kölzer M., Proia R.L., and Sandhoff K. Physiological substrates for human lysosomal β-hexosaminidase S. J. Biol. Chem. 277 (2002) 2562-2572
42. Navon R., and Proia R.L. The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the adult form of Tay-Sachs disease. Science 243 (1989) 1471-1474